维普中文期刊产品整合服务

Aging: A cell source limiting factor in tissue engineering

查看全文 作　　者：Mohammadhossein Khorraminejad-[1,2]Shirazi;Mohammadreza [1,2,3]Dorvash;Alireza [1,2]Estedlal;Amir Human [1]Hoveidaei;Mohsen [1,2]Mazloomrezaei;Pouria [1,2,3]Mosaddeghi 高影响力作者 机构地区：[1]Student Research Committee,Shiraz University of Medical Sciences,Shiraz 7134845794,Iran;[2]Cell and Molecular Medicine Student Research Group,School of Medicine,Shiraz University of Medical Sciences,Shiraz 7134845794,Iran;[3]Pharmaceutical Sciences Research Center,Shiraz University of Medical Sciences,Shiraz 7134814336,Iran高影响力机构 出　　处：《World Journal of Stem Cells》索引2019年第11卷第10期,共16页高影响力期刊 摘　　要：Tissue engineering has yet to reach its ideal goal,i.e.creating profitable off-theshelf tissues and organs,designing scaffolds and three-dimensional tissue architectures that can maintain the blood supply,proper biomaterial selection,and identifying the most efficient cell source for use in cell therapy and tissue engineering.These are still the major challenges in this field.Regarding the identification of the most appropriate cell source,aging as a factor that affects both somatic and stem cells and limits their function and applications is a preventable and,at least to some extents,a reversible phenomenon.Here,we reviewed different stem cell types,namely embryonic stem cells,adult stem cells,induced pluripotent stem cells,and genetically modified stem cells,as well as their sources,i.e.autologous,allogeneic,and xenogeneic sources.Afterward,we approached aging by discussing the functional decline of aged stem cells and different intrinsic and extrinsic factors that are involved in stem cell aging including replicative senescence and Hayflick limit,autophagy,epigenetic changes,miRNAs,mTOR and AMPK pathways,and the role of mitochondria in stem cell senescence.Finally,various interventions for rejuvenation and geroprotection of stem cells are discussed.These interventions can be applied in cell therapy and tissue engineering methods to conquer aging as a limiting factor,both in original cell source and in the in vitro proliferated cells. 关 键 词：AGING SENESCENCE REJUVENATION Geroprotection TISSUE engineering Stem CELL therapy
相关文献

参考文献(183)

引证文献(4)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费